<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="oil1000/PMC6532192/results/search/disease/results.xml">
  <result pre="anti-microbial, and anti-inflammatory effects as well as potential protection against" exact="cardiovascular disease," post="neurodegeneration, type 2 diabetes, and cancer. While interest in"/>
  <result pre="health benefits of herbs and spices include conferring protection against" exact="cardiovascular disease," post="neurodegenerative conditions, chronic inflammation, cancer, obesity, and type 2"/>
  <result pre="spices towards preventing or ameliorating chronic diseases such as cancer," exact="cardiovascular disease," post="arthritis, and neurodegeneration appear to be mediated through the"/>
  <result pre="ameliorating chronic diseases such as cancer, cardiovascular disease, arthritis, and" exact="neurodegeneration" post="appear to be mediated through the direct action of"/>
  <result pre="different doses each group (500, 1000, 2000, 4000, 8000 mg/day) 25" exact="cancer" post="HPLC-UV Serum (0 h, 0.5 h, 1 h, 1.5"/>
  <result pre="ability to increase the activity of the detoxifying system (potential" exact="cancer" post="chemoprevention). This finding was replicated in another study ["/>
  <result pre="[ 104]. Apigenin has also been identified as a potential" exact="cancer" post="chemopreventive agent [ 105]. The major essential oil found"/>
  <result pre="absorption and increase the efficacy in treating spastic colon and" exact="irritable bowel syndrome." post="Menthol is fat-soluble and therefore is rapidly absorbed from"/>
  <result pre="seizures, ulcers, gout, rheumatism, inflammation, dizziness, tremors, paralysis, diarrhea, and" exact="hyperglycemia" post="[ 128]. Sage has a savory, slightly peppery flavor."/>
  <result pre="pharmacokinetic studies with healthy volunteers [ 139, 144, 145] and" exact="colorectal cancer" post="patients [ 6] revealed that curcumin has a plasma"/>
  <result pre="studies with healthy volunteers [ 139, 144, 145] and colorectal" exact="cancer" post="patients [ 6] revealed that curcumin has a plasma"/>
  <result pre="&quot;curcuma&quot; extract per day (containing 36–180 mg of curcumin) in advanced" exact="colorectal cancer" post="patients. Another study performed by Cheng et al. ["/>
  <result pre="extract per day (containing 36–180 mg of curcumin) in advanced colorectal" exact="cancer" post="patients. Another study performed by Cheng et al. ["/>
  <result pre="Gescher AJ Consumption of the putative chemopreventive agent curcumin by" exact="cancer" post="patients: assessment of curcumin levels in the colorectum and"/>
  <result pre="X Lim J Henry CJ Spices in the management of" exact="diabetes mellitus" post="Food Chem 2017 217 281 293 10.1016/j.foodchem.2016.08.111 27664636 10."/>
  <result pre="and pharmacokinetic study of oral Curcuma extract in patients with" exact="colorectal cancer" post="Clin Cancer Res 2001 77 1894 1900 26. collab:"/>
  <result pre="pharmacokinetic study of oral Curcuma extract in patients with colorectal" exact="cancer" post="Clin Cancer Res 2001 77 1894 1900 26. collab:"/>
  <result pre="and human urine and modulation of the glutathione levels in" exact="cancer" post="cells by [6]-shogaol Mol Nutr Food Res 2013 573"/>
  <result pre="the major bioactive component in rosemary extract ameliorates high-fat diet-induced" exact="obesity" post="and metabolic syndrome in mice J Agric Food Chem"/>
  <result pre="bioactive component in rosemary extract ameliorates high-fat diet-induced obesity and" exact="metabolic syndrome" post="in mice J Agric Food Chem 2015 6319 4843"/>
  <result pre="105. Shukla S Gupta S Apigenin: a promising molecule for" exact="cancer" post="prevention Pharm Res 2010 276 962 978 10.1007/s11095-010-0089-7 106."/>
  <result pre="peppermint oil preparations, Colpermin and Mintec, for treatment of the" exact="irritable bowel syndrome" post="Int J Pharm 1987 401 151 155 10.1016/0378-5173(87)90060-3 117."/>
  <result pre="R Phase II trial of curcumin in patients with advanced" exact="pancreatic cancer" post="Clin Cancer Res 2008 1414 4491 4499 10.1158/1078-0432.CCR-08-0024 141."/>
  <result pre="Phase II trial of curcumin in patients with advanced pancreatic" exact="cancer" post="Clin Cancer Res 2008 1414 4491 4499 10.1158/1078-0432.CCR-08-0024 141."/>
  <result pre="the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in" exact="cancer" post="patients Cancer Chemother Pharmacol 2013 716 1521 1530 10.1007/s00280-013-2151-8"/>
 </snippets>
</snippetsTree>
